Neuroimmunology
- Number of publications
- 112
Publications
-
Higueras Y; Borges M; Jiménez-Martín I; Conde C; Aparicio-Mingueza A; Sierra-Martínez E; Gich-Fulla J; Balaguer-Marmaña M; Gil-Sánchez A; Anglada E; Jover A; Pérez-Martín MY; Arévalo MJ; Arrabal-Gómez C; Jiménez-Veiga J; Lubrini G; Molano A; García-Vaz F
Cognitive assessment in patients with multiple sclerosis: A Spanish consensus.
Frontiers In Rehabilitation Sciences 3 1006699-1006699. .
-
Saposnik, Gustavo; Andhavarapu, Sanketh; Sainz de la Maza S; Castillo-Trivino, Tamara; Borges, Monica; Baron, Beatriz Pardinas; Sotoca, Javier; Alonso, Ana; Caminero, Ana B.; Borrega, Laura; Sanchez-Menoyo, Jose L.; Barrero-Hernandez, Francisco J.; Calles, Carmen; Brieva, Luis; Blasco, Maria R.; -Soto, Julio Dotor Garcia; del Campo-Amigo, Maria; Navarro-Canto, Laura; Agüera E; Garces, Moises; Carmona, Olga; Gabaldon -Torres, Laura; Forero, Lucia; Hervas, Mariona; Garcia-Arcelay, Elena; Terzaghi, Maria; Gomez-Ballesteros, Rocio; Maurino, Jorge
Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosis.
Multiple Sclerosis and Related Disorders 68 104138-104138. .
-
Meca-Lallana, J E; Fernandez-Prada, M; Garcia Vazquez, E; Moreno Guillen, S; Otero Romero, S; Rus Hidalgo, M; Villar Guimerans, L M; Eichau Madueño S; Fernandez Fernandez, O; Izquierdo Ayuso, G; Álvarez Cermeño JC; Arnal Garcia, C; Arroyo Gonzalez, R; Brieva Ruiz, L; Calles Hernandez, C; Garcia Merino, A; Gonzalez Plata, M; Hernandez Perez, M A; Moral Torres, E; Olascoaga Urtaza, J; Oliva-Nacarino, P; Oreja-Guevara, C; Ortiz Castillo, R; Oterino, A; Prieto Gonzalez, J M; Ramio-Torrenta, L; Rodriguez-Antiguedad, A; Saiz, A; Tintore, M; Montalban Gairin, X
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.
Neurologia (barcelona, Spain) 37 615-630. .
-
Solari, A; Montalban, X; Lechner-Scott, J; Piehl, F; Brochet, B; Langdon, D; Hupperts, R; Selmaj, K; Havrdova, EK; Patti, F; Brieva, L; Maida, EM; Alexandri, N; Smyk, A; Nolting, A; Keller, B
Improvements in quality of life over 2 years in patients treated with cladribine tablets for highly active relapsing multiple sclerosis: Final analysis of CLARIFY-MS
MULTIPLE SCLEROSIS JOURNAL 28 203-204. .
-
Martín-Aguilar L.; Presas-Rodriguez S.; Rovira À.; Capellades J.; Massuet-Vilamajó A.; Ramió-Torrentà L.; Tintoré M.; Brieva-Ruiz L.; Moral E.; Cano-Orgaz A.; Blanco Y.; Batlle-Nadal J.; Carmona O.; Gea M.; Hervás-García J.V.; Ramo-Tello C.
Gadolinium-enhanced brain lesions in multiple sclerosis relapse
NEUROLOGIA 37 557-563. .
-
Gonzalez-Mingot, C; Lopez-Ortega, R; Brieva-Ruiz, L
The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2
NEUROLOGICAL SCIENCES 43 5099-5101. .
-
Castillo-Trivino, Tamara; Gomez-Ballesteros, Rocio; Borges, Monica; Martin-Martinez, Jesus; Sotoca, Javier; Alonso, Ana; Caminero, Ana B.; Borrega, Laura; Sanchez-Menoyo, Jose L.; Barrero-Hernandez, Francisco J.; Calles, Carmen; Brieva, Luis; Blasco-Quilez, Maria R.; Garcia-Soto, Julio Dotor; del Campo-Amigo, Maria; Navarro-Canto, Laura; Aguera, Eduardo; Garces-Redondo, Moises; Carmona, Olga; Gabaldon-Torres, Laura; Forero, Lucia; Hervas, Mariona; Mauriño J; Sainz de la Maza S
Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis.
Multiple Sclerosis and Related Disorders 64 103969-103969. .
-
Brieva, L; Estruch, BC; Merino JAG; Meca-Lallana, V; Rio, J; Rodriguez-Antigueedad, A; Aguera, E; Ara, JR; Luque, AA; Garcia, CA; Blanco, Y; Castillo-Trivino, T; Costa-Frossard, L; González Platas M; Pascual, LL; Llaneza-Gonzalez, M; Ginés MLM; Matias-Guiu, J; Meca-Lallana, JE; Bilbao, MM; Sempere, AP; Romero-Pinel, L; Saiz, A; Moral, E
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology.
Multiple Sclerosis and Related Disorders 63 103805-103805. .
-
Vermersch P; Brieva-Ruiz L; Fox RJ; Paul F; Ramio-Torrenta L; Schwab M; Moussy A; Mansfield C; Hermine O; Maciejowski M
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial.
Neurology-Neuroimmunology & Neuroinflammation 9 -. .
-
Sancho-Saldana, A; Gil Sánchez A; Quirant-Sanchez, B; Nogueras, L; Peralta, S; Solana, MJ; Gonzalez-Mingot, C; Gallego, Y; Quibus, L; Ramo-Tello, C; Presas-Rodriguez, S; Martinez-Caceres, E; Torres, P; Hervas, JV; Valls, J; Brieva, L
Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies.
Journal of Clinical Medicine 11 -. .
-
Fernández-Velasco JI; Monreal E; Kuhle J; Meca-Lallana V; Meca-Lallana J; Izquierdo G; Oreja-Guevara C; Gascón-Giménez F; Sainz de la Maza S; Walo-Delgado PE; Lapuente-Suanzes P; Maceski A; Rodríguez-Martín E; Roldán E; Villarrubia N; Saiz A; Blanco Y; Diaz-Pérez C; Valero-López G; Diaz-Diaz J; Aladro Y; Brieva L; Íñiguez C; González-Suárez I; Rodríguez de Antonio LA; García-Domínguez JM; Sabin J; Llufriu S; Masjuan J; Costa-Frossard L; Villar LM
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology.
Frontiers in Immunology 13 842354-842354. .
-
Sainz de la Maza S; Maurino J; Borges M; Martín-Martínez J; Sotoca J; Alonso A; Caminero AB; Borrega L; Sánchez-Menoyo JL; Barrero-Hernández FJ; Calles C; Brieva L; Blasco MR; García-Soto JD; Campo-Amigo MD; Navarro-Cantó L; Agüera E; Garcés M; Carmona O; Gabaldón-Torres L; Forero L; Hervás M; de Alda LR; Gómez-Ballesteros R; Castillo-Triviño T
Measuring productivity loss in early relapsing-remitting multiple sclerosis.
Multiple Sclerosis and Related Disorders 58 103398-103398. .